The Xeris-Strongbridge Merger Should Create Substantial Value For Shareholders

Zhanna Hapanovich/iStock via Getty Images
Xeris Pharmaceuticals (XERS) is a long-time holding of mine whose stock has really languished of late. This week Xeris announced that it was acquiring Strongbridge Biopharma (SBBP) in an all-stock and CVR deal worth…

Click here to view the original article.